Johnson & Johnson (J&J) was heavily criticized when it hired BroadSpire Services Inc. to handle the DePuy hip replacement recall.  Some critics claimed that to cut down on the expenses entailed in facing all complaints filed following the recall, DePuy is outsourcing the handling of the recall. J&J claimed that the recall will not have a material adverse effect on its finances; however, this may not be the case anymore with some artificial joint manufacturers talking of offshoring in wake of ...
Continue reading ...

The DePuy Orthopaedics, Inc. has been questioned with the way it handled its hip recall, which has resulted to various lawsuits filed.  According to critics, the company may have done it to save money rather than for the patients whose health may have been compromised more because of their defective hip implant devices. Amidst the company’s troubles, DePuy has passed another product through the beleaguered FDA approval process.

A worldwide recall has been announced by the DePuy Orthopaedics,...
Continue reading ...

Hip pain can be such a troublesome condition that we often experience. Sometimes, when we exert too much stress to our hips, the hip bone and hip joint could be traumatized. The hip bone and joints are constantly at work everyday. Even when we perform the simplest physical activities such as walking, sitting and running, we use our hip bone and joints. We can perform various movements thanks to our hip joints. When irreparable injury to the hip is experienced, an invasive and long-term surgic...
Continue reading ...

About four hundred complaints were received by the United States Food and Drugs Administration regarding the apparent adverse effects DePuy's ASR XL Acetabular System and ASR Hip Resurfacing System inflicts upon recipients resulting in the hip replacement recall. A series of studies conducted by foreign joint registries then prompted DePuy Orthopaedics to recall their products. Now, it would seem that the FDA is taking independent action to address adverse event reports that they have receiv...

Continue reading ...

Lawsuits began being filed when DePuy Orthopaedics issued a voluntary recall on two of their hip replacement devices, the ASR XL Acetabular System and the ASR Hip Resurfacing System. There were about 93,000 units of these implants that were sold worldwide and studies revealed that 11,000 recipients are affected causing them to need a risky and expensive hip revision surgery. Some of the symptoms experienced by affected patients are intense pain, swelling in the hip area, limited or loss of mo...

Continue reading ...

In August 2010, Johnson & Johnson subsidiary, DePuy Orthopaedics issued a voluntary recall of two of their hip replacement devices, the ASR XL Acetabular System and the ASR Hip Resurfacing System. Sold since 2003, the devices were found to have an inherent design flaw that makes for quick deterioration. ASR components rub on each other causing metal flakes to scrape off and get deposited in surrounding tissue, bone and sinew. It took joint registries from other countries to find out this data...

Continue reading ...